Fighting to save our cherished ones from deadly viruses 

Treating Companion Animal Viral Diseases

Having developed a novel broad spectrum oral anti-viral protein, Biovalence Sdn. Bhd. began to explore various fields where this would prove useful. To assist us in doing so, we’ve collaborated with numerous academic and research institutions:

We realised that one important field of application is companion animal viruses. These viruses plague our beloved cats and dogs, many of which cause incurable or high mortality disease in them worldwide.

As such, we have set our sights on viruses which cause among the most significant viral diseases in cats and dogs, and these are:

Feline Leukemia Virus (FeLV)

Feline Panleukopenia (FPV)

Canine Parvovirus 2 (CPV2)

Feline Immunodeficiency Virus (FIV)

Feline Infectious Peritonitis Virus (FIPV)

We believe that by targeting and ridding the disease-causing virus from the animal’s body, what then follows is a lessening of the burden placed on the animal’s immune system, allowing faster recovery of clinical symptoms and other secondary infections, assisting other administered supportive care/medication where applicable.

The following links are some of the feedback given by former trial participants:

For more technical information on RetroMAD1 and the companion animal field trial results click here

So where are we right now?

Biovalence Sdn. Bhd. has spent the last 8 years conducting research on RetroMAD1’s properties and capabilities. While we have acquired extensive research data it is still considered preliminary. Our next step is to work towards implementing the strict principles of Good Laboratory Practice (GLP), Good Clinical Practice (GCP), and Good Manufacturing Practice (GMP) in our research and manufacturing process. This is part of the regulatory requirement of the United States Food and Drug Administration (USFDA) and European Medicines Agency (EMA). These principles enable the collected data to carry more weight when used to support our marketing application for companion animals in the future.

We are continuously collecting more data to support our existing knowledge base. If you are interested in participating in our ongoing FIV and FeLV field trial, please visit here for more information.

We will continue to focus on targeting these viruses and in time to come, expand our field of research to other deadly companion animal viral diseases. Should you wish to support us in making a difference in the lives of our cherished cats and dogs, you may donate here to fund our research.